Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Gene Ther. 2009 Nov 5;17(2):227–237. doi: 10.1038/gt.2009.137

Figure 5. Amelioration of weight loss by rs40-CFTR gene therapy in Pseudomonas-infected cystic fibrosis (CF) mice.

Figure 5

Shown are the means ± standard deviations of the percent changes in weight after Pseudomonas-agarose bead intra-tracheal challenge for the CFTR−/− mice in the rS40-CFTR group and in rS40-BUGT-treated control group. N=4 for each timepoint. *p≤0.05 difference between the two groups.